“…It was reported that the vasorelaxing action of nicorandil may be, at least in part, due to an increase in produc tion of PGL [Neichi et al, 1980], cGMP [Holzmann, 1983] or membrane potassium conductance Karashima et al, 1982] of vascular smooth muscle. This mode of action differed from Ca2+ entry blockers, nitrate, papaverine or dipyrida mole [Taira, 1979;Nabata et al, 1981;Sakai et al, 1981], Furthermore, it was suggested that in isolated vascular smooth muscles the suppression of Ca2+ mobilization in the cell and agonist-induced Ca2+ entry may play an important role in the vasorelaxing action of nicorandil Karashima et al, 1982;Itoh et al, 1981;Shibata et al, 1984;Hester, 1985].…”